Omega-3 Fatty Acids: Key Players in Cognitive Function and Brain Health
DOI:
https://doi.org/10.12775/JEHS.2025.77.56776Keywords
Omega-3 fatty acids, DHA (Docosahexaenoic acid), EPA (Eicosapentaenoic acid), Long-chain polyunsaturated fatty acids (LCPUFAs), Brain health, Cognitive functions, Neurodegenerative diseases, Alzheimer's disease (AD), Mental health, Depression, SchizophreniaAbstract
Introduction:Omega-3 fatty acids, particularly DHA and EPA, are crucial for brain health. Modern diets, often lacking in omega-3, highlight their importance in combating cognitive decline, neurodegenerative diseases, and mental disorders.
Purpose of research:This study explores the roles of omega-3 fatty acids in brain health and cognitive functions, including their mechanisms of action and potential in preventing and alleviating neurodegenerative diseases.
Materials and methods:This study involves a comprehensive review of scientific literature on the impact of omega-3 fatty acids on brain health and cognitive functions. The literature search was conducted using PubMed and Google Scholar, focusing on peer-reviewed articles, clinical trials, and meta-analyses relevant to omega-3 fatty acids, brain health, cognitive functions, and mental health outcomes.
Results and conclusions:Research shows that DHA and EPA supplementation can significantly improve memory and learning, especially in older individuals and those with cognitive impairments. Omega-3s also show potential in reducing the risk of neurodegenerative diseases like Alzheimer's through their anti-inflammatory and antioxidant properties. In mental health, omega-3s can help reduce symptoms of depression and schizophrenia, although effectiveness depends on dosage and the EPA to DHA ratio. Omega-3s are essential for brain health and cognitive functions. Their supplementation, combined with cognitively stimulating activities, offers substantial benefits, especially in aging populations. Further research is needed to fully understand omega-3s' mechanisms, optimal dosing, and their use in preventing and treating neurological disorders.
References
1. Patted PG, Masareddy RS, Patil AS, Kanabargi RR, Bhat CT. Omega-3 fatty acids: a comprehensive scientific review of their sources, functions and health benefits. Futur J Pharm Sci [Internet]. 2024;10(1) http://dx.doi.org/10.1186/s43094-024-00667-5
2. Troesch B, Eggersdorfer M, Laviano A, Rolland Y, Smith AD, Warnke I, et al. Expert opinion on benefits of long-chain omega-3 fatty acids (DHA and EPA) in aging and clinical nutrition. Nutrients [Internet]. 2020;12(9):2555. http://dx.doi.org/10.3390/nu12092555
3. Wei B-Z, Li L, Dong C-W, Tan C-C, Alzheimer’s Disease Neuroimaging Initiative, Xu W. The relationship of omega-3 fatty acids with dementia and cognitive decline: Evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. Am J Clin Nutr [Internet]. 2023;117(6):1096–109.http://dx.doi.org/10.1016/j.ajcnut.2023.04.001
4. Serefko A, Jach ME, Pietraszuk M, Świąder M, Świąder K, Szopa A. Omega-3 polyunsaturated fatty acids in depression. Int J Mol Sci [Internet]. 2024;25(16):8675. http://dx.doi.org/10.3390/ijms25168675
5. Loong S, Barnes S, Gatto NM, Chowdhury S, Lee GJ. Omega-3 fatty acids, cognition, and brain volume in older adults. Brain Sci [Internet]. 2023;13(9). http://dx.doi.org/10.3390/brainsci13091278
6. Appleton KM, Voyias PD, Sallis HM, Dawson S, Ness AR, Churchill R, et al. Omega-3 fatty acids for depression in adults. Cochrane Database Syst Rev [Internet]. 2021;11(11):CD004692.http://dx.doi.org/10.1002/14651858.CD004692.pub5
7. Hsu M-C, Huang Y-S, Ouyang W-C. Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms. Lipids Health Dis [Internet]. 2020;19(1):159. http://dx.doi.org/10.1186/s12944-020-01337-0
8. Roy J, Vigor C, Vercauteren J, Reversat G, Zhou B, Surget A, et al. Characterization and modulation of brain lipids content of rainbow trout fed with 100% plant based diet rich in omega-3 long chain polyunsaturated fatty acids DHA and EPA. Biochimie [Internet]. 2020;178:137–47. http://dx.doi.org/10.1016/j.biochi.2020.06.010
9. Chakraborty N, Muhie S, Kumar R, Gautam A, Srinivasan S, Sowe B, et al. Contributions of polyunsaturated fatty acids (PUFA) on cerebral neurobiology: an integrated omics approach with epigenomic focus. J Nutr Biochem [Internet]. 2017;42:84–94. http://dx.doi.org/10.1016/j.jnutbio.2016.12.006
10. Gharami K, Das M, Das S. Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochem Int [Internet]. 2015;89:51–62. http://dx.doi.org/10.1016/j.neuint.2015.08.014
11. Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci [Internet]. 2015;7:52. http://dx.doi.org/10.3389/fnagi.2015.00052
12. Sueyasu T, Yasumoto K, Tokuda H, Kaneda Y, Obata H, Rogi T, et al. Effects of long-chain polyunsaturated fatty acids in combination with lutein and zeaxanthin on episodic memory in healthy older adults. Nutrients [Internet]. 2023;15(13). http://dx.doi.org/10.3390/nu15132825
13. Tokuda H, Horikawa C, Nishita Y, Kaneda Y, Obata H, Rogi T, et al. Association between a combination of cognitively stimulating leisure activities and long-chain polyunsaturated fatty acid intake on cognitive decline among community-dwelling older Japanese individuals. Front Aging Neurosci [Internet]. 2024;16:1406079. http://dx.doi.org/10.3389/fnagi.2024.1406079
14. Lázaro I, Grau-Rivera O, Suárez-Calvet M, Fauria K, Minguillón C, Shekari M, et al. Omega-3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer’s disease dementia. Alzheimers Dement (Amst) [Internet]. 2024;16(3):e12596. http://dx.doi.org/10.1002/dad2.12596
15. Sun GY, Simonyi A, Fritsche KL, Chuang DY, Hannink M, Gu Z, et al. Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins Leukot Essent Fatty Acids [Internet]. 2018;136:3–13. http://dx.doi.org/10.1016/j.plefa.2017.03.006
16. Mora I, Arola L, Caimari A, Escoté X, Puiggròs F. Structured long-chain omega-3 fatty acids for improvement of cognitive function during aging. Int J Mol Sci [Internet]. 2022;23(7):3472. http://dx.doi.org/10.3390/ijms23073472
17. Wang Y-W, Li Q, Li X-Y, Zhao Y-C, Wang C-C, Xue C-H, et al. A comparative study about the neuroprotective effects of DHA-enriched phosphatidylserine and EPA-enriched phosphatidylserine against oxidative damage in primary hippocampal neurons. Mar Drugs [Internet]. 2023;21(7):410. http://dx.doi.org/10.3390/md21070410
18. Stavrinou PS, Andreou E, Aphamis G, Pantzaris M, Ioannou M, Patrikios IS, et al. The effects of a 6-month high dose omega-3 and omega-6 polyunsaturated fatty acids and antioxidant vitamins supplementation on cognitive function and functional capacity in older adults with mild cognitive impairment. Nutrients [Internet]. 2020;12(2):325. http://dx.doi.org/10.3390/nu12020325
19. Kelaiditis CF, Gibson EL, Dyall SC. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials. Prostaglandins Leukot Essent Fatty Acids [Internet]. 2023;192(102572):102572.http://dx.doi.org/10.1016/j.plefa.2023.102572
20. Liao Y, Xie B, Zhang H, He Q, Guo L, Subramanieapillai M, et al. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Transl Psychiatry [Internet]. 2019;9(1):190. http://dx.doi.org/10.1038/s41398-019-0515-5
21. Godos J, Micek A, Currenti W, Franchi C, Poli A, Battino M, et al. Fish consumption, cognitive impairment and dementia: an updated dose-response meta-analysis of observational studies. Aging Clin Exp Res [Internet]. 2024;36(1):171. http://dx.doi.org/10.1007/s40520-024-02823-6
22. Saini RK, Prasad P, Sreedhar RV, Akhilender Naidu K, Shang X, Keum Y-S. Omega-3 polyunsaturated fatty acids (PUFAs): Emerging plant and microbial sources, oxidative stability, bioavailability, and health benefits-A review. Antioxidants (Basel) [Internet]. 2021;10(10):1627.http://dx.doi.org/10.3390/antiox10101627
23. Omega-3 fatty acids [Internet]. Nih.gov. [cited 2024 Dec 3]. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
24. Zhang Y-P, Miao R, Li Q, Wu T, Ma F. Effects of DHA supplementation on hippocampal volume and cognitive function in older adults with mild cognitive impairment: A 12-month randomized, double-blind, placebo-controlled trial. J Alzheimers Dis [Internet]. 2016;55(2):497–507.http://dx.doi.org/10.3233/jad-160439
25. Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr [Internet]. 2012;3(1):1–7. http://dx.doi.org/10.3945/an.111.000893
26. Mengelberg A, Leathem J, Podd J, Hill S, Conlon C. The effects of docosahexaenoic acid supplementation on cognition and well-being in mild cognitive impairment: A 12-month randomised controlled trial. Int J Geriatr Psychiatry [Internet]. 2022;37(5). http://dx.doi.org/10.1002/gps.5707
27. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial: A randomized trial. JAMA [Internet]. 2010;304(17):1903–11.http://dx.doi.org/10.1001/jama.2010.1510
28. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA J [Internet]. 2012;10(7). http://dx.doi.org/10.2903/j.efsa.2012.2815
29. Robinson DG, Gallego JA, John M, Hanna LA, Zhang J-P, Birnbaum ML, et al. A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone. Schizophr Res [Internet]. 2019;204:295–303.http://dx.doi.org/10.1016/j.schres.2018.09.006
30. Abubakari A-R, Naderali M-M, Naderali EK. Omega-3 fatty acid supplementation and cognitive function: are smaller dosages more beneficial? Int J Gen Med [Internet]. 2014;7:463–73. http://dx.doi.org/10.2147/IJGM.S67065
31. Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, Drago F, et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell Longev [Internet]. 2014;2014:313570. Available from: http://dx.doi.org/10.1155/2014/313570
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Wiktoria Wesołowska, Emilia Bachoń, Michalina Doligalska, Aleksandra Stremel, Agnieszka Leszyńska, Julia Linke, Zuzanna Bałoniak, Dominika Kozłowska, Julia Bałoniak, Weronika Tuszyńska
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 224
Number of citations: 0